510(k) K130282
K130282 is an FDA 510(k) premarket notification submitted by Remington Medical, Inc. for the device "REMINGTON MEDICAL CENTREFIRE 22 BIOPSY INSTRUMENT". The FDA issued a decision of Substantially Equivalent on May 13, 2013. The device falls under product code KNW (Instrument, Biopsy), a Class II device regulated under 21 CFR 876.1075. Remington Medical, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 13, 2013
- Date Received
- February 5, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- Yes
Device Classification
- Device Name
- Instrument, Biopsy
- Device Class
- Class II
- Regulation Number
- 876.1075
- Review Panel
- SU
- Submission Type